Europe Probiotics Market by Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Global Forecast to 2030

icon1
USD 20.56
MARKET SIZE, 2030
icon2
CAGR 5.5%
(2025-2030)
icon3
250
REPORT PAGES
icon4
200
MARKET TABLES

OVERVIEW

europe-probiotics-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The probiotics market in Europe is estimated to be USD 15.73 billion in 2025 and is projected to reach USD 20.56 billion by 2030, registering a CAGR of 5.5% from 2025 to 2030. The market is witnessing steady growth, driven by the increasing adoption of functional foods, preventive healthcare, and digestive health solutions across food & beverages, dietary supplements, pharmaceuticals, and animal nutrition industries. As consumer preferences continue to shift toward natural, microbiome-supporting, and clean-label health solutions, probiotics derived from bacterial and yeast strains such as Lactobacillus and Bifidobacterium are gaining wider commercial relevance as scientifically supported functional ingredients.

KEY TAKEAWAYS

  • BY COUNTRY
    Russia accounted for the largest share (21.1%) of the probiotics market in Europe in 2024.
  • BY PRODUCT TYPE
    By product type, the dietary supplements segment is expected to register the highest CAGR of 7.7% during the forecast period.
  • BY INGREDIENTS
    By ingredient, the bacteria segment dominated the market in 2024 with an 88.3% share.
  • BY DISTRIBUTION CHANNEL
    By distribution channel, the online retail segment is expected to witness the fastest growth during the forecast period.
  • BY END USER
    By end user, the human segment is estimated to dominate the market.
  • Competitive Landscape – Key Players
    Key players include Danone S.A., Probi AB, and Nestlé S.A., supported by established brands, clinical research capabilities, and extensive regional distribution networks.

The probiotics market in Europe is projected to reach USD 20.56 billion by 2030, registering a CAGR of 5.5% during the forecast period. The market is poised for steady growth, supported by rising demand for products that promote digestive wellness and immune support. Increasing use of probiotics across foods, beverages, and supplements, along with greater consumer awareness of gut health, is strengthening market momentum. Innovation in convenient and shelf-stable formats, paired with expanding retail availability, is further driving adoption. Continued investment in evidence-based probiotic solutions is expected to support long-term market development.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Current revenues are concentrated in a narrow range of core applications, which are mainly traditional functional food and beverage formats, but over time, this mix is expected to change. Future revenues will come from new use cases and new technologies, improved products, partnerships, and target market penetration. Emerging segments are expected to hold a bigger share of total revenues, which underlines changes across product type and ingredients, sales channels, and end-use areas. It points to a structural shift in the market. Client imperatives across functional foods and beverages, dietary supplements, and animal nutrition are dynamic and evolving. Companies are focusing on clean labels, food safety, freshness, stable live cultures, lower waste, sustainable processing, better nutrient absorption, cost control, scale-up ability, and regulatory fit. These requirements are directly translated into measurable downstream outcomes across end-use sectors. In food and beverages, they would entail lower usage of synthetic preservatives with longer shelf life, stronger digestive health claims, and clearer labeling of sources. In feed, outcomes are reflected in a healthier gut, stronger immunity, and reduced antibiotic dependence. In personal care and wellness-oriented applications, the outcomes are reflected in enhanced microbiome balance, improved product compatibility through gut-skin positioning, and lower use of synthetic functional additives. All these shifts point out how the changing client needs are redefining the demand across the probiotics value chain in Europe.

europe-probiotics-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • •Growing consumer focus on digestive health and immunity
  • •Increasing clinical validation of probiotic strains
RESTRAINTS
Impact
Level
  • §Strict regulatory scrutiny by EFSA
  • §Higher production and formulation costs
OPPORTUNITIES
Impact
Level
  • §Rising preference for natural and preventive health solutions
  • §Growth in personalized nutrition and microbiome-based solutions
CHALLENGES
Impact
Level
  • §Complexities in integrating probiotics in functional foods
  • §Intolerance of probiotics to stomach acid and bile

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing consumer focus on digestive health and immunity

The growing interest of consumers in digestive health, the immune system, and preventive health is a major demand driver for probiotics in Europe. The market is driven by rising awareness of gut-microbiome benefits. The demand for probiotic yogurts, fermented dairy products, and drinks with added benefits continues to be strong in countries such as Germany, France, the UK, and Italy, thus contributing to the overall market growth. Digestive discomfort, health issues associated with lifestyle, and recovery post-antibiotic consumption are slowly becoming common. Consequently, consumers now include probiotic foods and supplements as part of their daily diets. The growing preference for clean-label, scientifically proven ingredients, as well as recommendations from health care professionals, are additional factors that support the continuous growth of probiotics consumption in Europe.

Restraint: Strict regulatory scrutiny by EFSA

The primary restraint on probiotic manufacturers is regulatory oversight by the European Food Safety Authority (EFSA), which has rigorous requirements for health claim approvals and strain validation. EFSA places very strict scientific standards. This makes it harder for brands to communicate functional benefits on product labels, thereby slowing new product launches and limiting marketing flexibility. The demand for extensive clinical evidence adds to the development timelines and costs. This is a challenge, particularly for small companies, which typically have limited R&D capacity. Additionally, the differences in regulatory interpretation among different European markets make it relatively more difficult for a manufacturer to scale up probiotic foods and supplements.

Opportunity: Rising preference for natural and preventive health solutions

The shift toward natural and self-care choices in Europe is creating definite growth avenues for probiotic foods and supplements. Consumers increasingly seek products that contribute to gut health and immunity. Most consumers prefer this over medication. The transition is opening up a way to new product concepts. Manufacturers are devising plant-based probiotics, shelf-stable drinks, products for women's health, and targeted microbiome solutions. Moreover, there is an increase in personalized nutrition, and microbiome testing is also growing, opening up new avenues in product development for probiotics for particular age groups and specific health needs.

Challenge: Complexities in integrating probiotics in functional foods

A key challenge in the probiotics market in Europe is adding live cultures to food and beverages without compromising their quality. This means that the strains must remain active, have an acceptable flavor, and survive through shelf life. Many strains are vulnerable to heat, oxygen, and certain processing conditions, which complicates the formulation and manufacturing procedures. The stability of probiotics during storage and transport, particularly under cold-chain restrictions, is an added cost and operational burden. These limitations narrow the framework of food-and-beverage categories that can safely accommodate probiotics. This is necessitating ongoing investment in encapsulation technologies, fermentation capabilities, and product efficacy testing.

EUROPE PROBIOTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Probiotic fermented milk drinks for daily digestive health consumption Supports gut balance, improves digestion, and helps strengthen immunity
Probiotic infant formulas and medical nutrition products designed for early-life and clinical use Improves nutrient absorption, supports immune development, and enhances digestive tolerance
Probiotic yogurt and drinking yogurt for functional food applications Enhances digestive comfort, supports immune health, and meets clean-label preferences
Probiotic drops, tablets, and oral health products Provides digestive relief, supports infant gut health, and improves overall wellness

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The probiotics market in Europe is growing, wherein food, beverage, and healthcare manufacturers are applying probiotic solutions in support of digestive health, immunity, and general wellness. Probiotics have a wide range of applications in functional foods, supplements, medical nutrition, and animal feeds to restore gut balance and nutrient absorption. The market growth in the region is also fostered through a strong base of fermentation capabilities, a mature dairy processing industry, rising preferences for natural and clean-label products, and stringent EFSA-led regulatory standards that channel toward scientific validation and preventive health. Increasing consumer awareness of microbiome health, combined with a gradual shift toward sustainable bio-based nutrition, continues to maintain the status of probiotics as a major player in food and healthcare innovation today. With long-term wellness taking precedence among European consumers, probiotics are expected to be one of the key drivers of product development across diverse areas of application.

europe-probiotics-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

europe-probiotics-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Europe Probiotics Market, By Ingredient

The probiotics market in Europe is estimated to be dominated by the bacteria segment, which is supported by the extensive application of Lactobacillus, Bifidobacterium, and Streptococcus in yogurts, fermented dairy drinks, infant formulas, dietary supplements, and animal feed. These strains capture the market as they are supported by clinical studies in digestive health, immunity, and microbiome balance. Besides that, Europe has great fermentation capabilities, a mature dairy industry, and strict EFSA safety and quality standards. The strong position of strain suppliers and the good cold-chain systems also contribute to the bacteria segment's growth in major European countries. While the demand for yeast-based probiotics is growing gradually in niche applications, bacterial probiotics are still competitive because they are familiar to consumers, have higher strain diversity, and have proven product performance. Hence, they will retain a larger market share.

Europe Probiotics Market, By Distribution Channel

By distribution channel, the hypermarkets & supermarkets segment is estimated to account for the largest share of the probiotics market in Europe. This is due to the large number of products available, high consumer purchases, and the broad presence of these stores in both urban and rural areas. These large-scale stores are preferred by consumers for buying probiotic yogurts, fermented dairy drinks, fortified beverages, and an ever-growing assortment of probiotic dietary supplements. The combination of their low prices, regular promotions, and a well-functioning cold-chain system all contribute to the selling of probiotic products that are sensitive to temperature while ensuring that the products are safe and of good quality. Even though online platforms and pharmacy chains are making steady progress, especially for supplement products, hypermarkets and supermarkets remain the most preferred and commercially important channel owing to their convenience, wide brand availability, and capacity to generate high-volume sales in European countries.

Europe Probiotics Market, By Product Type

By product type, the functional foods and beverages segment is estimated to dominate the probiotics market in Europe. This is supported by strong consumption of probiotic-rich yogurts, fermented milk drinks, kefir, cultured dairy products, and fortified beverages across major countries such as Germany, the UK, France, Italy, and the Nordics. This segment leads due to Europe’s mature dairy industry, high consumer trust in fermented foods, and rising focus on digestive wellness and immunity. Food manufacturers continue to introduce new probiotic formulations with clean-label positioning, natural ingredients, and clinically supported strains, further strengthening market adoption. While probiotic dietary supplements are expanding rapidly, especially among consumers seeking targeted gut health and immunity benefits, functional foods and beverages remain the dominant category because of their daily-use appeal, strong retail penetration, and long-standing integration in European diets.

REGION

UK to be fastest-growing country in Europe probiotics market during forecast period

The UK is anticipated to be the fastest-growing market for probiotics in Europe during the forecast period. Growth is being driven by a strong consumer focus on digestive health, immunity, and functional nutrition. Demand for probiotic yogurts, fermented drinks, and dietary supplements is high, and consumption of plant-based and shelf-stable probiotic products is also increasing. The UK has an established retail environment. This supports the growth of the probiotics market. High penetration of online sales, coupled with the increasing roles of pharmacies and health stores, is improving the availability of these products. Medical professionals are also influencing consumer uptake and awareness about microbiome health. Additionally, companies are investing in research and development of products with clean label claims and are focusing on scientifically validated benefits along with easy-to-use formats. As brands provide science-backed wellness solutions in more convenient delivery formats, the UK will remain the fastest-growing market in the region throughout the period of prediction.

europe-probiotics-market Region

EUROPE PROBIOTICS MARKET: COMPANY EVALUATION MATRIX

A competitive landscape framework for the probiotics market in Europe classifies companies as Stars, Emerging Leaders, Participants, or Pervasive Players based on their innovation capabilities, market reach, and growth prospects. Danone is positioned as a Star, supported by its strong leadership in probiotic yogurts and fermented dairy drinks, extensive European distribution network, and continuous investment in clinically supported formulations. Kerry is identified as an Emerging Leader, driven by its expanding probiotic ingredient portfolio, including BC30, and its growing role in supplying functional food and beverage manufacturers across the region. Participants typically include niche or country-specific brands with focused portfolios, while Pervasive Players maintain established market presence but show limited innovation momentum relative to category leaders.

europe-probiotics-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 14.99 Billion
Market Forecast in 2030 (Value) USD 20.56 Billion
Growth Rate CAGR of 5.5% from 2025 to 2030
Years Considered 2020–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Billion), Volume (Kilotons)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Product Type:
    • Functional Food & Beverages (Dairy Products
    • Non-dairy Beverages
    • Infant Formula
    • Cereals
    • Other Functional Food & Beverages)
    • Dietary Supplements (Tablets
    • Capsules
    • Powders
    • Liquids
    • Soft Gels
    • Gel Caps)
    • Feed
  • By Ingredient:
    • Bacteria (Lactobacillix
    • Lactobacillus Acidophilus
    • Lactobacillus Rhamnosus
    • Lactobacillus Casei
    • Lactobacillus Reuteri
    • Bifidobacterium
    • Streptococcus Thermophilus)
    • Yeast (Saccharomyces Boulardii
    • Other Yeasts)
  • By Distribution Channel:
    • Hypermarkets/Supermarkets
    • Pharmacies/Drugstores
    • Specialty Stores
    • Online
    • Convenience Stores/Small Retail Formats
  • By End User:
    • Human
    • Animal
Countries Covered Russia, UK, Italy, Germany, Spain, Rest of Europe

WHAT IS IN IT FOR YOU: EUROPE PROBIOTICS MARKET REPORT CONTENT GUIDE

europe-probiotics-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Probiotic Ingredients Market
  • Competitive benchmarking of probiotic ingredient suppliers
  • Assessment of strain potency, stability, and application fit
  • Review of regional regulatory guidelines
  • Identified high-performing strains suitable for new formulations
  • Highlighted key regulatory considerations for functional food and supplement claims
  • Provided direction for supplier prioritization and sourcing strategy
Digestive Health Supplements Market
  • Mapping of leading probiotic formulations across capsules, sachets, and gummies
  • Analysis of multi-strain vs. single-strain products
  • Review of pricing structures and claim-based positioning
  • Identified whitespace opportunities for targeted digestive and immunity solutions
  • Supported development of differentiated claim strategies
  • Offered insights to optimize pricing and channel competitiveness
Animal Nutrition Probiotics Market
  • Benchmarking of probiotic feed additive suppliers
  • Species-level adoption analysis for poultry, swine, cattle, and aquaculture
  • Review of efficacy claims and feed regulatory requirements
  • Identified growth opportunities across key livestock and aquaculture categories
  • Clarified buyer priorities and adoption barriers
  • Informed product positioning for regional expansion in antibiotic-reduction programs

RECENT DEVELOPMENTS

  • November 2025 : Probi expanded its offering with new probiotic applications targeting Sports & Active Nutrition and Pet Health, broadening its science-based solutions beyond traditional human digestive benefits.
  • June 2025 : Danone completed the acquisition of The Akkermansia Company (TAC), a Belgium-based biotics specialist, giving Danone access to the proprietary strain Akkermansia muciniphila to expand its next-generation gut health offerings.
  • February 2021 : Probi entered into a long-term partnership with Perrigo, a major consumer-health player in Europe, to expand the distribution of clinically supported probiotic products targeting digestive health and immunity across major EU markets.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
 
4
MARKET OVERVIEW
This section summarizes market dynamics, key shifts, and high-impact trends shaping demand outlook.
 
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
4.2.1.1
GROWING CONSUMER FOCUS ON DIGESTIVE HEALTH AND IMMUNITY
 
 
 
 
 
4.2.1.2
INCREASING CLINICAL VALIDATION OF PROBIOTIC STRAINS
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
4.2.2.1
STRICT REGULATORY SCRUTINY BY EFSA
 
 
 
 
 
4.2.2.2
HIGHER PRODUCTION AND FORMULATION COSTS
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
4.2.3.1
RISING PREFERENCE FOR NATURAL AND PREVENTIVE HEALTH SOLUTIONS
 
 
 
 
 
4.2.3.2
GROWTH IN PERSONALIZED NUTRITION AND MICROBIOME-BASED SOLUTIONS
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
4.2.4.1
COMPLEXITIES IN INTEGRATING PROBIOTICS IN FUNCTIONAL FOODS
 
 
 
 
 
4.2.4.2
INTOLERANCE OF PROBIOTICS TO STOMACH ACID AND BILE
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
5
INDUSTRY TRENDS
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
 
 
 
 
 
 
5.1
PORTER'S FIVE FORCES ANALYSIS
 
 
 
 
 
5.2
MACROECONOMICS INDICATORS
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL PROBIOTICS INDUSTRY
 
 
 
 
 
5.2.4
TRENDS IN EUROPE PROBIOTICS INDUSTRY
 
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE (2020–2024)
 
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND, BY INGREDIENTS (2020–2024)
 
 
 
 
 
5.6.3
AVERAGE SELLING PRICE TREND, BY REGION (2020–2024)
 
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE)
 
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE)
 
 
 
 
5.8
KEY CONFERENCES AND EVENTS IN 2025–2026
 
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
5.10
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
5.11
CASE STUDY ANALYSIS
 
 
 
 
 
5.12
IMPACT OF 2025 US TARIFF – EUROPE PROBIOTICS MARKET
 
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
 
5.12.2
KEY TARIFF RATES
 
 
 
 
 
5.12.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
5.12.4
IMPACT ON COUNTRIES
 
 
 
 
 
5.12.5
IMPACT ON END-USE INDUSTRIES
 
 
 
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS
 
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
6.3
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
6.4
PATENT ANALYSIS
 
 
 
 
 
 
6.5
FUTURE APPLICATIONS
 
 
 
 
 
6.6
IMPACT OF AI/GEN AI ON EUROPE PROBIOTICS MARKET
 
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
6.6.2
BEST PRACTICES IN EUROPE PROBIOTICS MARKET
 
 
 
 
 
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN EUROPE PROBIOTICS MARKET
 
 
 
 
 
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN EUROPE PROBIOTICS MARKET
 
 
 
 
6.7
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
 
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
 
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
 
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
 
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
9
EUROPE PROBIOTICS MARKET, BY PRODUCT TYPE (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
 
 
 
 
 
 
TYPE-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS
 
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
 
9.2
FUNCTIONAL FOOD & BEVERAGES
 
 
 
 
 
 
9.2.1
STRONG POPULARITY OF FERMENTED DAIRY FOODS AND HIGH COMPATIBILITY OF EUROPEAN DIETS WITH PROBIOTICS
 
 
 
 
 
9.2.2
DAIRY PRODUCTS
 
 
 
 
 
9.2.3
NONDAIRY BEVERAGES
 
 
 
 
 
9.2.4
INFANT FORMULA
 
 
 
 
 
9.2.5
CEREALS
 
 
 
 
 
9.2.6
OTHER FUNCTIONAL FOOD & BEVERAGES
 
 
 
 
9.3
DIETARY SUPPLEMENTS
 
 
 
 
 
 
9.3.1
HIGH CONSUMER TRUST IN CLINICALLY SUPPORTED PROBIOTIC SUPPLEMENTS
 
 
 
 
 
9.3.2
TABLETS
 
 
 
 
 
9.3.3
CAPSULES
 
 
 
 
 
9.3.4
POWDERS
 
 
 
 
 
9.3.5
LIQUIDS
 
 
 
 
 
9.3.6
SOFT GELS
 
 
 
 
 
9.3.7
GEL CAPS
 
 
 
 
9.4
FEED
 
 
 
 
 
 
9.4.1
SHIFT TOWARD SUSTAINABLE, ANTIBIOTIC-FREE PRACTICES
 
 
 
10
EUROPE PROBIOTICS MARKET, BY INGREDIENT (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
 
 
 
 
 
 
INGREDIENT-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS
 
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
 
10.2
BACTERIA
 
 
 
 
 
 
10.2.1
GROWING RELIANCE ON CLINICALLY VALIDATED BACTERIAL STRAINS FOR GUT HEALTH AND IMMUNE SUPPORT TO DRIVE MARKET
 
 
 
 
 
10.2.2
LACTOBACILLIX
 
 
 
 
 
 
10.2.2.1
LACTOBACILLUS ACIDOPHILUS
 
 
 
 
 
10.2.2.2
LACTOBACILLUS RHAMNOSUS
 
 
 
 
 
10.2.2.3
LACTOBACILLUS CASEI
 
 
 
 
 
10.2.2.4
LACTOBACILLUS REUTERI
 
 
 
 
10.2.3
BIFIDOBACTERIUM
 
 
 
 
 
10.2.4
STREPTOCOCCUS THERMOPHILUS
 
 
 
 
10.3
YEAST
 
 
 
 
 
 
10.3.1
INCREASING USE OF PROBIOTIC YEASTS FOR GASTROINTESTINAL BALANCE AND HIGH-STABILITY FORMULATIONS TO FUEL MARKET
 
 
 
 
 
10.3.2
SACCHAROMYCES BOULARDII
 
 
 
 
 
10.3.3
OTHER YEASTS
 
 
 
11
EUROPE PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
 
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
 
11.2
HYPERMARKETS/SUPERMARKETS
 
 
 
 
 
 
11.2.1
WIDE RETAIL COVERAGE AND PROBIOTIC ASSORTMENTS IN EUROPEAN SUPERMARKETS TO DRIVE MARKET
 
 
 
 
11.3
PHARMACIES/DRUGSTORES
 
 
 
 
 
 
11.3.1
HIGH PURCHASE OF PROBIOTIC SUPPLEMENTS THROUGH TRUSTED PHARMACY CHANNELS TO BOOST MARKET
 
 
 
 
11.4
SPECIALTY STORES
 
 
 
 
 
 
11.4.1
GROWING SHOPPER INTEREST IN TARGETED AND PREMIUM PROBIOTIC FORMULATIONS TO DRIVE MARKET
 
 
 
 
11.5
ONLINE
 
 
 
 
 
 
11.5.1
EXPANSION OF E-COMMERCE AND SUBSCRIPTION-BASED PROBIOTIC PURCHASES TO DRIVE THE MARKET
 
 
 
 
11.6
CONVENIENCE STORES/SMALL RETAIL FORMATS
 
 
 
 
 
 
11.6.1
EASY ACCESS TO SINGLE-SERVE PROBIOTIC BEVERAGES AND SUPPLEMENTS TO BOOST THE MARKET
 
 
 
12
EUROPE PROBIOTICS MARKET, BY END USER (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
 
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
 
12.2
HUMAN
 
 
 
 
 
 
12.2.1
GROWING USE OF PROBIOTIC FOODS AND SUPPLEMENTS FOR DAILY DIGESTIVE HEALTH TO DRIVE MARKET
 
 
 
 
12.3
ANIMAL
 
 
 
 
 
 
12.3.1
INCREASING ADOPTION OF PROBIOTICS IN PET AND LIVESTOCK DIETS FOR GUT HEALTH SUPPORT TO BOOST MARKET
 
 
 
13
EUROPE PROBIOTICS MARKET, BY REGION
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
 
13.1
EUROPE
 
 
 
 
 
 
13.1.1
RUSSIA
 
 
 
 
 
 
13.1.1.1
GROWING CONSUMPTION OF FERMENTED DAIRY PRODUCTS LIKE KEFIR TO DRIVE MARKET
 
 
 
 
13.1.2
UK
 
 
 
 
 
 
13.1.2.1
RISING ADOPTION OF PROBIOTIC SUPPLEMENTS AMID STRONG DIGESTIVE HEALTH AWARENESS TO BOOST MARKET
 
 
 
 
13.1.3
ITALY
 
 
 
 
 
 
13.1.3.1
HIGH USE OF PROBIOTICS FOR GUT AND IMMUNE SUPPORT TO FUEL MARKET
 
 
 
 
13.1.4
GERMANY
 
 
 
 
 
 
13.1.4.1
STRONG DEMAND FOR CLINICALLY VALIDATED PROBIOTIC FORMULATIONS TO DRIVE MARKET
 
 
 
 
13.1.5
SPAIN
 
 
 
 
 
 
13.1.5.1
INCREASING INTAKE OF PROBIOTIC-FORTIFIED DAIRY AND FUNCTIONAL FOODS TO BOOST MARKET
 
 
 
 
13.1.6
REST OF EUROPE
 
 
 
14
COMPETITIVE LANDSCAPE
 
 
 
 
 
 
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
 
 
 
 
 
 
 
14.1
OVERVIEW
 
 
 
 
 
14.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
14.2.1
COMPETITIVE STRATEGIES INITIATIVES
 
 
 
 
14.3
REVENUE ANALYSIS, 2022–2024
 
 
 
 
 
 
14.4
MARKET SHARE ANALYSIS,
 
 
 
 
 
 
14.5
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
14.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
 
14.6.1
STARS
 
 
 
 
 
14.6.2
EMERGING LEADERS
 
 
 
 
 
14.6.3
PERVASIVE PLAYERS
 
 
 
 
 
14.6.4
PARTICIPANTS
 
 
 
 
 
14.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
 
14.6.5.1
COMPANY FOOTPRINT
 
 
 
 
 
14.6.5.2
REGION FOOTPRINT
 
 
 
 
 
14.6.5.3
TYPE FOOTPRINT
 
 
 
 
 
14.6.5.4
APPLICATION FOOTPRINT
 
 
 
14.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
 
14.7.1
PROGRESSIVE COMPANIES
 
 
 
 
 
14.7.2
RESPONSIVE COMPANIES
 
 
 
 
 
14.7.3
DYNAMIC COMPANIES
 
 
 
 
 
14.7.4
STARTING BLOCKS
 
 
 
 
 
14.7.5
COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES
 
 
 
 
 
 
14.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
14.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
14.8
COMPETITIVE SCENARIO
 
 
 
 
 
 
14.8.1
PRODUCT LAUNCHES
 
 
 
 
 
14.8.2
DEALS
 
 
 
 
 
14.8.3
EXPANSIONS
 
 
 
 
 
14.8.4
OTHER DEVELOPMENTS
 
 
 
15
COMPANY PROFILES
 
 
 
 
 
 
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE EUROPE PROBIOTICS MARKET LANDSCAPE
 
 
 
 
 
 
15.1
KEY PLAYERS
 
 
 
 
 
 
15.1.1
DANONE S.A.
 
 
 
 
 
 
15.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.1.3
MNM VIEW
 
 
 
 
 
 
15.1.1.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.1.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.1.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.2
PROBI AB
 
 
 
 
 
 
15.1.2.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.2.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.2.3
MNM VIEW
 
 
 
 
 
 
15.1.2.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.2.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.2.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.3
NESTLÉ S.A.
 
 
 
 
 
 
15.1.3.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.3.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.3.3
MNM VIEW
 
 
 
 
 
 
15.1.3.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.3.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.3.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.4
YAKULT HONSHA CO., LTD.
 
 
 
 
 
 
15.1.4.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.4.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.4.3
MNM VIEW
 
 
 
 
 
 
15.1.4.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.4.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.4.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.5
BIOGAIA AB
 
 
 
 
 
 
15.1.5.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.5.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.5.3
MNM VIEW
 
 
 
 
 
 
15.1.5.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.5.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.5.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.6
CHR. HANSEN HOLDING A/S
 
 
 
 
 
 
15.1.6.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.6.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.6.3
MNM VIEW
 
 
 
 
 
 
15.1.6.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.6.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.6.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.7
DAFLORN PROBIOTICS LTD.
 
 
 
 
 
 
15.1.7.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.7.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.7.3
MNM VIEW
 
 
 
 
 
 
15.1.7.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.7.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.7.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.8
KERRY GROUP PLC
 
 
 
 
 
 
15.1.8.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.8.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.8.3
MNM VIEW
 
 
 
 
 
 
15.1.8.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.8.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.8.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.9
ARLA FOODS
 
 
 
 
 
 
15.1.9.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.9.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.9.3
MNM VIEW
 
 
 
 
 
 
15.1.9.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.9.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.9.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.10
AB-BIOTICS S.A.
 
 
 
 
 
 
15.1.10.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.10.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.10.3
MNM VIEW
 
 
 
 
 
 
15.1.10.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.10.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.10.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.11
PEPSICO
 
 
 
 
 
 
15.1.11.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.11.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.11.3
MNM VIEW
 
 
 
 
 
 
15.1.11.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.11.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.11.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.12
INSTITUT ALLERGOSAN
 
 
 
 
 
 
15.1.12.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.12.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.12.3
MNM VIEW
 
 
 
 
 
 
15.1.12.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.12.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.12.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.13
GENERAL MILLS
 
 
 
 
 
 
15.1.13.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.13.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.13.3
MNM VIEW
 
 
 
 
 
 
15.1.13.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.13.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.13.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.14
INTERNATIONAL FLAVOURS & FRAGRANCES INC.
 
 
 
 
 
 
15.1.14.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.14.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.14.3
MNM VIEW
 
 
 
 
 
 
15.1.14.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.14.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.14.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
15.1.15
SABINSA CORPORATION
 
 
 
 
 
 
15.1.15.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.15.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.15.3
MNM VIEW
 
 
 
 
 
 
15.1.15.3.1
KEY STRENGTHS
 
 
 
 
 
15.1.15.3.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.15.3.3
WEAKNESSES/COMPETITIVE THREATS
 
 
15.2
OTHER PLAYERS
 
 
 
 
 
 
15.2.1
NOVOZYMES
 
 
 
 
 
 
15.2.1.1
BUSINESS OVERVIEW
 
 
 
 
 
15.2.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.2.1.3
MNM VIEW
 
 
 
 
15.2.2
SANOFI
 
 
 
 
 
 
15.2.2.1
BUSINESS OVERVIEW
 
 
 
 
 
15.2.2.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.2.2.3
MNM VIEW
 
 
 
 
15.2.3
PANTHERYX
 
 
 
 
 
 
15.2.3.1
BUSINESS OVERVIEW
 
 
 
 
 
15.2.3.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.2.3.3
MNM VIEW
 
 
 
 
 
15.2.3.4
SACCO SYSTEM
 
 
 
 
 
15.2.3.5
BUSINESS OVERVIEW
 
 
 
 
 
15.2.3.6
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.2.3.7
MNM VIEW
 
 
 
 
15.2.4
TEVA PHARMACEUTICALS
 
 
 
 
 
 
15.2.4.1
BUSINESS OVERVIEW
 
 
 
 
 
15.2.4.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.2.4.3
MNM VIEW
 
 
 
 
15.2.5
WINCLOVE PROBIOTICS
 
 
 
 
 
 
15.2.5.1
BUSINESS OVERVIEW
 
 
 
 
 
15.2.5.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.2.5.3
MNM VIEW
 
 
16
RESEARCH METHODOLOGY
 
 
 
 
 
 
16.1
RESEARCH DATA
 
 
 
 
 
 
16.1.1
SECONDARY DATA
 
 
 
 
 
 
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
16.1.2
PRIMARY DATA
 
 
 
 
 
 
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
16.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
16.1.2.4
KEY INDUSTRY INSIGHTS
 
 
 
16.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
16.2.1
BOTTOM-UP APPROACH
 
 
 
 
 
16.2.2
TOP-DOWN APPROACH
 
 
 
 
 
16.2.3
BASE NUMBER CALCULATION
 
 
 
 
16.3
MARKET FORECAST APPROACH
 
 
 
 
 
 
16.3.1
SUPPLY SIDE
 
 
 
 
 
16.3.2
DEMAND SIDE
 
 
 
 
16.4
DATA TRIANGULATION
 
 
 
 
 
16.5
FACTOR ANALYSIS
 
 
 
 
 
16.6
RESEARCH ASSUMPTIONS
 
 
 
 
 
16.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
 
17
APPENDIX
 
 
 
 
 
 
17.1
DISCUSSION GUIDE
 
 
 
 
 
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
17.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
17.4
RELATED REPORTS
 
 
 
 
 
17.5
AUTHOR DETAILS
 
 
 
 

Methodology

This research involves the extensive use of secondary sources; directories; and databases (Bloomberg and Factiva) to identify and collect information useful for a technical, market-oriented, and commercial study of the Europe Probiotics market. In-depth interviews were conducted with various primary respondents, such as key industry participants, Subject Matter Experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess prospects.

Secondary Research

In the secondary research process, various sources, such as the Food and Agricultural Organization (FAO), United States Department of Agriculture (USDA), U.S. Food and Drug Administration (FDA) U.S. Food and Drug Administration (FDA), European Food Safety Authority (EFSA), World Health Organization (WHO), Consumer Healthcare Products Association (CHPA), European Federation of Associations of Health Product Manufacturers (EHPM), Canadian Health Food Association (CHFA), and Health Food Manufacturers' Association (HFMA), associations were referred to identify and collect information for this study. The secondary sources also include journals, press releases, investor presentations of companies, whitepapers, certified publications, articles by recognized authors and regulatory bodies, trade directories, and paid databases.

Primary Research

The Europe Probiotics market encompasses various stakeholders involved in the supply chain, raw material manufacturers, raw material suppliers, regulatory organizations, and research institutions. To gather comprehensive information, primary sources from both the supply and demand sides were engaged. Primary interviewees from the supply side consisted of manufacturers, distributors, importers, and technology providers involved in the production and distribution of Probiotics. On the demand side, key opinion leaders, executives, and CEOs of companies in the Probiotics industry were approached through questionnaires, emails, and telephonic interviews. This approach ensured a comprehensive and well-rounded understanding of the Europe Probiotics market from various perspectives.

Market Size Estimation

The top-down and bottom-up approaches were used to estimate and validate the market’s and various dependent submarkets’ size. The research methodology used to estimate the market size includes extensive secondary research of key players, reports, reviews, and newsletters of top market players, along with extensive interviews from leaders, such as CEOs, directors, and marketing executives.

Europe Probiotics market: Data Triangluation

After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

Market Definition

The joint Food and Agriculture Organization (FAO)/World Health Organization (WHO) working group defines probiotics as “live micro-organisms, which when administered in adequate amounts confer a health benefit on the host” (FAO/ WHO, 2001).

Probiotics are living microorganisms that have been shown to provide specific health benefits to consumers. They are known to support gut health and help in running the digestive system smoothly. Yogurt is one of the prime natural sources of probiotics.

According to the National Center for Complementary and Integrative Health, “Probiotics are live microorganisms that are intended to have health benefits when consumed or applied to the body.” The major function of probiotics is to maintain a healthy balance in the body. Several types of microorganisms are present in probiotics, and they may have different effects on the body. The most common bacteria belong to the group called Lactobacillus and Bifidobacterium.

Key Stakeholders

  • Manufacturers, Importers and Exporters, Traders, Distributors, and Suppliers of Probiotics
  • Nutraceutical Manufacturers
  • Food Processors and Manufacturers
  • Government and Research Organizations
  • Trade Associations and Industry Bodies
  • Regulatory bodies and associations are as follows:
    • Food Agriculture Organization (FAO)
    • World Health Organization (WHO)
    • International Dairy Federation (IDF)
    • European Food & Feed Cultures Association (EFFCA)
    • National Yogurt Association (NYA)
    • International Scientific Association for Probiotics and Prebiotics (ISAPP)
    • International Probiotics Association (IPA)
    • Council for Responsible Nutrition (CRN)
    • National Yogurt Association (NYA)
    • International Frozen Yogurt Association (IFYA)
    • American Nutrition Association (ANA)

Report Objectives

  • To define, segment, and project the global market for Probiotics on the basis of product type, ingredient, distribution channel, end user, and region 
  • To provide detailed information regarding the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micro markets with respect to individual growth trends, future prospects, and their contribution to the total market
  • To analyze the opportunities in the market for stakeholders and provide a competitive landscape of the market leaders
  • To project the size of the market and its submarkets, in terms of value with respect to the regions (along with the key countries)
  • To strategically profile the key players and comprehensively analyze their market position and core competencies
  • To analyze competitive developments in the Europe Probiotics market, including joint ventures, mergers & acquisitions, new product developments, and research & development activities

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

  • Further breakdown of the Rest of the Europe Probiotics market, by key country
  • Further breakdown of the Rest of the Asia Pacific Probiotics market, by key country
  • Further breakdown of the Rest of South America Probiotics market, by key country

Company Information

  • Detailed analyses and profiling of additional market players

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Europe Probiotics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Europe Probiotics Market

DMCA.com Protection Status